199 related articles for article (PubMed ID: 31122179)
1. Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.
Pi WS; Cao ZY; Liu JM; Peng AF; Chen WZ; Chen JW; Huang SH; Liu ZL
Technol Cancer Res Treat; 2018; 18():1533033819853262. PubMed ID: 31122179
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling.
He JY; Xi WH; Zhu LB; Long XH; Chen XY; Liu JM; Luo QF; Zhu XP; Liu ZL
Tumour Biol; 2015 May; 36(5):3895-902. PubMed ID: 25874486
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.
Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH
Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
6. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
7. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
8. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
9. The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells.
Tan B; Yuan Z; Zhang Q; Xiqiang X; Dong J
J Appl Biomed; 2021 Dec; 19(4):190-201. PubMed ID: 34907738
[TBL] [Abstract][Full Text] [Related]
10. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
[TBL] [Abstract][Full Text] [Related]
14. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
15. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
16. LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
Liu G; Yuan D; Sun P; Liu W; Wu PF; Liu H; Yu GY
J Cell Physiol; 2018 Nov; 233(11):8639-8647. PubMed ID: 29904919
[TBL] [Abstract][Full Text] [Related]
17. BRCA1-Associated Protein-1 Suppresses Osteosarcoma Cell Proliferation and Migration Through Regulation PI3K/Akt Pathway.
Gao S; Sun H; Cheng C; Wang G
DNA Cell Biol; 2017 May; 36(5):386-393. PubMed ID: 28256910
[TBL] [Abstract][Full Text] [Related]
18. [Aurora kinase-B silencing promotes apoptosis of osteosarcoma 143B cells by ULK1 phosphorylation-induced autophagy].
Wu X; Liu J; Song H; Yang Q; Ying H; Liu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1273-1279. PubMed ID: 32990233
[TBL] [Abstract][Full Text] [Related]
19. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
[TBL] [Abstract][Full Text] [Related]
20. MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway.
Lu S; Liao QS; Tang L
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7633-7639. PubMed ID: 30536304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
